![Adora Ndu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 719 943 $ al 31/05/2026
La Dra. Adora Ndu es vicepresidenta de Investigación y Desarrollo a nivel mundial en BioMarin Pharmaceutical, Inc. Forma parte del Consejo de Administración de DBV Technologies SA. La Dra. Ndu trabajó anteriormente como miembro de la Universidad de Maryland. Se licenció en la Facultad de Derecho Francis King Carey de la Universidad de Maryland y se doctoró en la Facultad de Medicina de la Universidad Howard.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/05/2026 | 32.908 ( 0,02 % ) | 712 787 $ | 31/05/2026 | |
| 15/04/2026 | 1.825 ( 0 % ) | 7 156 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DBV TECHNOLOGIES | Director/Miembro de la Junta | 19/05/2021 |
| BRIDGEBIO PHARMA, INC. | Consejero General | 01/01/2022 |
| ACADIA PHARMACEUTICALS INC. | Director/Miembro de la Junta | 10/10/2022 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Director Técnico/Científico/I+D | 01/01/2022 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The University of Maryland Francis King Carey School of Law
 The University of Maryland Francis King Carey School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
 Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
